BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 22791606)

  • 1. Vaccinia virus protein C4 inhibits NF-κB activation and promotes virus virulence.
    Ember SWJ; Ren H; Ferguson BJ; Smith GL
    J Gen Virol; 2012 Oct; 93(Pt 10):2098-2108. PubMed ID: 22791606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccinia Virus BBK E3 Ligase Adaptor A55 Targets Importin-Dependent NF-κB Activation and Inhibits CD8
    Pallett MA; Ren H; Zhang RY; Scutts SR; Gonzalez L; Zhu Z; Maluquer de Motes C; Smith GL
    J Virol; 2019 May; 93(10):. PubMed ID: 30814284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccinia virus protein C16 acts intracellularly to modulate the host response and promote virulence.
    Fahy AS; Clark RH; Glyde EF; Smith GL
    J Gen Virol; 2008 Oct; 89(Pt 10):2377-2387. PubMed ID: 18796705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccinia virus inhibits NF-κB-dependent gene expression downstream of p65 translocation.
    Sumner RP; Maluquer de Motes C; Veyer DL; Smith GL
    J Virol; 2014 Mar; 88(6):3092-102. PubMed ID: 24371075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Filamin B restricts vaccinia virus spread and is targeted by vaccinia virus protein C4.
    Georgana I; Scutts SR; Gao C; Lu Y; Torres AA; Ren H; Emmott E; Men J; Oei K; Smith GL
    J Virol; 2024 Mar; 98(3):e0148523. PubMed ID: 38412044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccinia virus K1 ankyrin repeat protein inhibits NF-κB activation by preventing RelA acetylation.
    Bravo Cruz AG; Shisler JL
    J Gen Virol; 2016 Oct; 97(10):2691-2702. PubMed ID: 27503790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Camelpox virus encodes a schlafen-like protein that affects orthopoxvirus virulence.
    Gubser C; Goodbody R; Ecker A; Brady G; O'Neill LAJ; Jacobs N; Smith GL
    J Gen Virol; 2007 Jun; 88(Pt 6):1667-1676. PubMed ID: 17485525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of apoptosis and NF-κB activation by vaccinia protein N1 occur via distinct binding surfaces and make different contributions to virulence.
    Maluquer de Motes C; Cooray S; Ren H; Almeida GM; McGourty K; Bahar MW; Stuart DI; Grimes JM; Graham SC; Smith GL
    PLoS Pathog; 2011 Dec; 7(12):e1002430. PubMed ID: 22194685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leaky scanning translation generates a second A49 protein that contributes to vaccinia virus virulence.
    Neidel S; Torres AA; Ren H; Smith GL
    J Gen Virol; 2020 May; 101(5):533-541. PubMed ID: 32100702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccinia virus protein K7 is a virulence factor that alters the acute immune response to infection.
    Benfield CTO; Ren H; Lucas SJ; Bahsoun B; Smith GL
    J Gen Virol; 2013 Jul; 94(Pt 7):1647-1657. PubMed ID: 23580427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral double-stranded RNAs from vaccinia virus early or intermediate gene transcripts possess PKR activating function, resulting in NF-kappaB activation, when the K1 protein is absent or mutated.
    Willis KL; Langland JO; Shisler JL
    J Biol Chem; 2011 Mar; 286(10):7765-7778. PubMed ID: 21183678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccinia virus protein C6 is a virulence factor that binds TBK-1 adaptor proteins and inhibits activation of IRF3 and IRF7.
    Unterholzner L; Sumner RP; Baran M; Ren H; Mansur DS; Bourke NM; Randow F; Smith GL; Bowie AG
    PLoS Pathog; 2011 Sep; 7(9):e1002247. PubMed ID: 21931555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccinia virus protein N2 is a nuclear IRF3 inhibitor that promotes virulence.
    Ferguson BJ; Benfield CTO; Ren H; Lee VH; Frazer GL; Strnadova P; Sumner RP; Smith GL
    J Gen Virol; 2013 Sep; 94(Pt 9):2070-2081. PubMed ID: 23761407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poxviral regulation of the host NF-kappaB response: the vaccinia virus M2L protein inhibits induction of NF-kappaB activation via an ERK2 pathway in virus-infected human embryonic kidney cells.
    Gedey R; Jin XL; Hinthong O; Shisler JL
    J Virol; 2006 Sep; 80(17):8676-85. PubMed ID: 16912315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The vaccinia virus O1 protein is required for sustained activation of extracellular signal-regulated kinase 1/2 and promotes viral virulence.
    Schweneker M; Lukassen S; Späth M; Wolferstätter M; Babel E; Brinkmann K; Wielert U; Chaplin P; Suter M; Hausmann J
    J Virol; 2012 Feb; 86(4):2323-36. PubMed ID: 22171261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of the
    Bravo Cruz AG; Han A; Roy EJ; Guzmán AB; Miller RJ; Driskell EA; O'Brien WD; Shisler JL
    J Virol; 2017 Aug; 91(15):. PubMed ID: 28490586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccinia virus protein A49 is an unexpected member of the B-cell Lymphoma (Bcl)-2 protein family.
    Neidel S; Maluquer de Motes C; Mansur DS; Strnadova P; Smith GL; Graham SC
    J Biol Chem; 2015 Mar; 290(10):5991-6002. PubMed ID: 25605733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccinia virus BTB-Kelch proteins C2 and F3 inhibit NF-κB activation.
    Zhang RY; Pallett MA; French J; Ren H; Smith GL
    J Gen Virol; 2022 Oct; 103(10):. PubMed ID: 36301238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A soluble chemokine-binding protein from vaccinia virus reduces virus virulence and the inflammatory response to infection.
    Reading PC; Symons JA; Smith GL
    J Immunol; 2003 Feb; 170(3):1435-42. PubMed ID: 12538705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping the IkappaB kinase beta (IKKbeta)-binding interface of the B14 protein, a vaccinia virus inhibitor of IKKbeta-mediated activation of nuclear factor kappaB.
    Benfield CT; Mansur DS; McCoy LE; Ferguson BJ; Bahar MW; Oldring AP; Grimes JM; Stuart DI; Graham SC; Smith GL
    J Biol Chem; 2011 Jun; 286(23):20727-35. PubMed ID: 21474453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.